The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BIO FINANCIAL STATEMENTS

Bio-Rad Laboratories Inc — balance sheet, income statement and cash flow trends

BIOBio-Rad Laboratories Inc

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-5 B05 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue2.6 B $Gross Profit1.3 B $ · 52%Operating Income235 M $ · 9%Pre-tax Income350.4 M $ · 14%Net Income to Owners222.4 M $ · 9%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue2.6 B $+1.4%
Gross Profit1.3 B $-0.4%
Operating Income235 M $+5.1%
EBITDA534.6 M $-22.1%
Net Income to Owners222.4 M $-30.3%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
010 B20 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets10.3 B
  • Equity7.2 B $70%
  • Current Liabilities961.3 M $9%
  • Long-term Liabilities2.1 B $21%

Key Figures

YoY change
Total Assets10.3 B $+0.4%
Total Liabilities3.1 B $-0.2%
Total Equity7.2 B $+0.6%
Cash & ST Investments1.6 B $+17.8%
Total Debt1.2 B $-14.4%
Net Debt686.7 M $-33.8%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0250 M500 M750 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M400 M492.6 M $Operating-237.1 M $Investing-120.8 M $Financing134.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow492.6 M $-7.8%
Capital Expenditures139.5 M $-25.3%
Free Cash Flow353.1 M $+1.6%
Dividends Paid13.7 M $-78.8%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.